MOMETAZON FUROAT FOR ATOPIC DERMATITIS IN CHILDREN
Atopic dermatitis is one of the most prevalent reasons for skin lesions in the infancy. The medications of the first line therapy for this disease are topic glucocorticosteroids (TGCS). The survey has analyzed the efficiency of a new TGCS — mometazon furoat — for treating atopic dermatitis of childr...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2007-10-01
|
| Series: | Педиатрическая фармакология |
| Online Access: | https://www.pedpharma.ru/jour/article/view/724 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849244115382829056 |
|---|---|
| author | T.S. Shaipov L.P. Mazitova |
| author_facet | T.S. Shaipov L.P. Mazitova |
| author_sort | T.S. Shaipov |
| collection | DOAJ |
| description | Atopic dermatitis is one of the most prevalent reasons for skin lesions in the infancy. The medications of the first line therapy for this disease are topic glucocorticosteroids (TGCS). The survey has analyzed the efficiency of a new TGCS — mometazon furoat — for treating atopic dermatitis of children. The action mechanism of this medication is connected with the suppression of proinflammatory cytokinins synthesis (Il6, Il1, TNF). Mometazon furoat has clear anti inflammatory, antipruritic and anti exudative action. The treatment results proved high efficiency of the medication both for noncomplicated atopic dermatitis and for atopic dermatitis complicated with a secondary infection.Key words: atopic dermatitis, topic glucocorticosteroids, therapy, children. |
| format | Article |
| id | doaj-art-03d8537fb4864c24a4dfdde7b48f5ec1 |
| institution | Kabale University |
| issn | 1727-5776 2500-3089 |
| language | Russian |
| publishDate | 2007-10-01 |
| publisher | Union of pediatricians of Russia |
| record_format | Article |
| series | Педиатрическая фармакология |
| spelling | doaj-art-03d8537fb4864c24a4dfdde7b48f5ec12025-08-20T03:59:16ZrusUnion of pediatricians of RussiaПедиатрическая фармакология1727-57762500-30892007-10-01454144720MOMETAZON FUROAT FOR ATOPIC DERMATITIS IN CHILDRENT.S. Shaipov0L.P. Mazitova1Scientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowAtopic dermatitis is one of the most prevalent reasons for skin lesions in the infancy. The medications of the first line therapy for this disease are topic glucocorticosteroids (TGCS). The survey has analyzed the efficiency of a new TGCS — mometazon furoat — for treating atopic dermatitis of children. The action mechanism of this medication is connected with the suppression of proinflammatory cytokinins synthesis (Il6, Il1, TNF). Mometazon furoat has clear anti inflammatory, antipruritic and anti exudative action. The treatment results proved high efficiency of the medication both for noncomplicated atopic dermatitis and for atopic dermatitis complicated with a secondary infection.Key words: atopic dermatitis, topic glucocorticosteroids, therapy, children.https://www.pedpharma.ru/jour/article/view/724 |
| spellingShingle | T.S. Shaipov L.P. Mazitova MOMETAZON FUROAT FOR ATOPIC DERMATITIS IN CHILDREN Педиатрическая фармакология |
| title | MOMETAZON FUROAT FOR ATOPIC DERMATITIS IN CHILDREN |
| title_full | MOMETAZON FUROAT FOR ATOPIC DERMATITIS IN CHILDREN |
| title_fullStr | MOMETAZON FUROAT FOR ATOPIC DERMATITIS IN CHILDREN |
| title_full_unstemmed | MOMETAZON FUROAT FOR ATOPIC DERMATITIS IN CHILDREN |
| title_short | MOMETAZON FUROAT FOR ATOPIC DERMATITIS IN CHILDREN |
| title_sort | mometazon furoat for atopic dermatitis in children |
| url | https://www.pedpharma.ru/jour/article/view/724 |
| work_keys_str_mv | AT tsshaipov mometazonfuroatforatopicdermatitisinchildren AT lpmazitova mometazonfuroatforatopicdermatitisinchildren |